Literature DB >> 8001688

DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.

T Onogi1, M Minami, Y Katao, T Nakagawa, Y Aoki, T Toya, S Katsumata, M Satoh.   

Abstract

The structural basis of mu-opioid receptor (OPR) for the specificity in its ligand binding was investigated using chimeric mu/delta-OPRs. Replacement of the region around the first extracellular loop of delta-OPR with the corresponding region of mu-OPR gave the resultant chimeric receptor the similar affinity to DAMGO compared with the native mu-OPR. The reciprocal replacement deprived the high affinity to DAMGO from mu-OPR. These results indicate that the difference(s) in the structure around the first extracellular loop is critical for DAMGO to distinguish between mu- and delta-OPRs. Furthermore, displacement studies revealed that this region is partly involved in the discrimination between mu- and delta-OPRs by other peptidic mu-selective ligands, such as dermorphin, morphiceptin and CTOP, but not by non-peptidic ligands, such as morphine and naloxone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8001688     DOI: 10.1016/0014-5793(94)01341-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors.

Authors:  M Filizola; M Carteni-Farina; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

2.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

Authors:  P A Claude; D R Wotta; X H Zhang; P L Prather; T M McGinn; L J Erickson; H H Loh; P Y Law
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.

Authors:  H Ueda; M Inoue; T Matsumoto
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

4.  The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.

Authors:  J Pil; J Tytgat
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Authors:  Chris M Brasel; Gregory W Sawyer; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

6.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

7.  Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.

Authors:  W W Wang; M Shahrestanifar; J Jin; R D Howells
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

8.  Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Rats.

Authors:  Samuel Obeng; Jenny L Wilkerson; Francisco León; Morgan E Reeves; Luis F Restrepo; Lea R Gamez-Jimenez; Avi Patel; Anna E Pennington; Victoria A Taylor; Nicholas P Ho; Tobias Braun; John D Fortner; Morgan L Crowley; Morgan R Williamson; Victoria L C Pallares; Marco Mottinelli; Carolina Lopera-Londoño; Christopher R McCurdy; Lance R McMahon; Takato Hiranita
Journal:  J Pharmacol Exp Ther       Date:  2020-12-31       Impact factor: 4.030

9.  Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.

Authors:  Kori L Brewer; Christine A Baran; Brian R Whitfield; A Marley Jensen; Stefan Clemens
Journal:  Front Neural Circuits       Date:  2014-06-11       Impact factor: 3.492

10.  Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"?

Authors:  Robert Root-Bernstein; Miah Turke; Udaya K Tiruttani Subhramanyam; Beth Churchill; Joerg Labahn
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.